RACHEL RANG: Open Payments
NPI 1104321249 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 39 payments from 16 companies in 2025. Trend: 2023 $274 · 2024 $356 · 2025 $795
Food & beverage: $695Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $201 |
| Astellas Pharma US Inc | 1 | $100 |
| Janssen Biotech, Inc. | 4 | $87 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Geron Corporation | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Genentech USA, Inc. | 2 | $40 |
| Agios Pharmaceuticals, Inc. | 1 | $29 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $28 |
| Incyte Corporation | 1 | $26 |
Products named: KISQALI, JEMPERLI, RYTELO, PLUVICTO, RYBREVANT, KEYTRUDA QLEX, PYRUKYND, ZYNLONTA.
Industry payments across MI — which companies pay providers there.
